The Network Advantage: We can define speed but why can’t we define quality in clinical research?
THE NETWORK ADVANTAGE – LIVE WEBINAR The Network Advantage: We can define speed but why can’t we define quality in clinical research? Join the Association of Multisite Research Corporations (AMRC) for an exclusive webinar unpacking the key findings from our latest whitepaper and industry consultation on quality in multisite clinical research.https://www.youtube.com/watch?v=YfXpQojCixQ REGISTER FOR THE WEBINAR 18 […]
The Network Advantage: A Regulatory Perspective on Clinical Research Innovation
THE NETWORK ADVANTAGE – LIVE WEBINAR The Network Advantage: A Regulatory Perspective on Clinical Research Innovation In this informative session, clinical trial professionals will have an opportunity to hear directly from the FDA’s David Burrow on ways industry can advance clinical trial innovation. David will discuss the Center for Drug Evaluation and Research (CDER) Center […]
The Network Advantage: identifying the pain points that stop Sponsors and CROs from working with sites
THE NETWORK ADVANTAGE – LIVE WEBINAR Identifying the pain points that stop Sponsors and CROs from working with sites In this candid conversation, representatives from the clinical trial ecosystem will discuss how they can work with sites more effectively. We will use the session to identify key issues and blockers that prevent Sponsors and CROs […]
Capitol Hill Forecast – What Should MCRCs Prepare For?
THE NETWORK ADVANTAGE – LIVE WEBINAR Capitol Hill Forecast – What Should MCRCs Prepare For? Join Patrick Cooney, a seasoned expert with bipartisan insight into healthcare policy, as we explore the federal government’s priorities and funding outlook for clinical research.https://www.youtube.com/watch?v=ei0YaYJ_0AU REGISTER FOR THE WEBINAR Wednesday, 26 March – 10am PST / 1pm EST / 5pm UTC […]
Webinar
LIVE WEBINAR Operational inefficiency in clinical research: what is it costing Sponsors and CROs? The Association of Multisite Research Corporations (AMRC) welcomes a panel of experts to discuss the financial and operational impact of inefficiency in clinical trials. We’ll be joined by representatives from regulatory, academic, pharma, and trial sites, who will share their perspectives […]
